BioLineRx (BLRX) Interest & Investment Income (2012 - 2025)
BioLineRx (BLRX) recorded quarterly Interest & Investment Income of $1.2 million in Q3 2025, up 48.09% quarter-over-quarter from $784000.0 in Q2 2025, and down 24.32% on a YoY basis from $1.5 million in Q3 2024.
BioLineRx (BLRX) Interest & Investment Income (2012 - 2025) Analysis & Trends
BioLineRx's Interest & Investment Income history runs 14 years deep, the most recent figure standing at $1.2 million for Q3 2025.
- In Q3 2025, Interest & Investment Income fell 24.32% year-over-year to $1.2 million; the TTM figure through Sep 2025 stood at $1.2 million (down 24.32% YoY), while the FY2025 annual figure was $1.5 million, down 21.75% from the prior year.
- Interest & Investment Income was $1.2 million for Q3 2025 at BioLineRx, up from $784000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.5 million in Q3 2024 to a low of $67000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $624933.3 across 5 years, with a median of $537000.0 in 2023.
- The sharpest annual moves came in 2023 and 2025: Interest & Investment Income soared 701.49% in 2023, then tumbled 47.96% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $299000.0 in 2021, then declined by 14.38% to $256000.0 in 2022, then soared by 403.52% to $1.3 million in 2023, then advanced by 19.01% to $1.5 million in 2024, then fell by 24.32% to $1.2 million in 2025.
- The last three Interest & Investment Income figures came in at $1.2 million (Q3 2025), $784000.0 (Q2 2025), and $294000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | BioLineRx | 227.63 Mn | 211.90 Mn | 154,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | 784,000.00 |
| Mar 31, 2025 | 294,000.00 |
| Sep 30, 2024 | 1.53 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 565,000.00 |
| Sep 30, 2023 | 1.29 Mn |
| Jun 30, 2023 | 977,000.00 |
| Mar 31, 2023 | 537,000.00 |
| Sep 30, 2022 | 256,000.00 |
| Jun 30, 2022 | 147,000.00 |
| Mar 31, 2022 | 67,000.00 |
| Sep 30, 2021 | 299,000.00 |
| Jun 30, 2021 | 247,000.00 |
| Mar 31, 2021 | 117,000.00 |
| Sep 30, 2020 | 214,000.00 |
| Jun 30, 2020 | 175,000.00 |
| Mar 31, 2020 | 140,000.00 |
| Sep 30, 2019 | 628,000.00 |
| Jun 30, 2019 | 381,000.00 |